A new antibiotic, ripostatin, was isolated from the culture supernatant of the myxobacterium, Sorangium cellulosum strain So ce377. It is a macrocyclic lactone carbonic acid containing an unsubstituted phenyl ring in a side chain. The antibiotic acts especially on Staphylococcus aureus, but seems not to penetrate most bacteria.
In our screening programwe found in the culture supernatant of Sorangiumcellulosum, strain So ce377 an activity against certain Gram-positive bacteria. The antibiotic complex contained two compounds. They were named ripostatin A and B.
In this paper we describe the production and some chemical and biological properties. The structure elucidation is described elsewhereX). Production of Ripostatin The producing organism was isolated by us in 1989 from a soil sample from Kenya. In preliminary experiments in shake flasks, it was found that antibiotic synthesis occured during the growth phase ( Table 1 ). The following medium was used: Soluble starch, 0.3%; MgSO4-7H2O, 0.15%; CaCl2-2H2O, 0.1%; K2HPO4 0.0125%; Glucose H2O, 0.3%; Na-Fe-(III)-EDTA, 8mg/liter (all from Merck, Darmstadt); yeast extract, 0.17% (Difco); HEPES, 0.1 % (Serva); soya meal, 0.05%; pH 7.5. In order to obtain larger quantities, the antibiotic was produced in a fermentor containing 300 liters of mediumand equipped with a circulating pump stirrer system (Giovanola Freres, Monthey, Switzerland). The mediumused was as mentioned above, but soluble starch was replaced by potato starch, HEPESbuffer was omitted, and 0.3% fructose and 0.01 % pyruvic acid were added, because these substances had a positive effect on the production of ripostatin. Further, the adsorber resin XAD-16 (1%, v/v; Rohm and Haas) and silicone antifoam (0.1 ml/liter; Tegosipon, Goldschmidt AG) were added. The fermentation was started with 30 liters from a seed fermentor. The temperature was 30°C, the aeration rate 0.3 m3 air/hour, the stirring rate was 300rpm. After 65 hours the pO2 had dropped from 100% to 30%
saturation. It slowly decreased further to 15% until the end of fermentation 144 hours after inoculation. At this time the glucose was consumed, and 30mgripostatin/ liter had been produced. All antibiotic was bound to the adsorber resin. In other, small-scale fermentations potato starch was replaced with good results by wheat or rye flour, which were muchcheaper than purified starch.
Isolation and SomePhysico-chemical Data The XADwas separated from the culture, and the antibiotic was isolated as described elsewhere1}. Briefly, the XADwas eluted with methanol. Ripostatin was isolated from this extract by preparative HPLCon silica gel RP 8. Fig. 1 shows the chemical structures of the ripostatins. Figs. 2 and 3 give the electronic absorption spectrum of ripostatin A in methanol and the IR spectrum in KBr.
Biological Properties The antibiotic spectrum is shown in Table 2 . Ripostatin A and B were active only against a few bacteria. The two components had nearly the same inhibitory effects. a At maximal yield, the content ofripostatin B was about 1/10 of that of component A.
b Cells began to lump.
100 ml of medium in 250-ml flasks, cultivated on a rotary shaker at 160rpm, 30°C. Mediumas described in the text.
Yeasts and fungi were not influenced by ripostatin A. But component B showed minor activity against several yeasts and fungi. The MICs ofripostatin A and B against cultivated mouse fibroblasts were identical and rather high. The effect of ripostatin A on viability of E. coli tol C is shown in Fig. 4 . The bacteria were cultivated in nutrient broth in the presence ofripostatin A. At different times, the cell suspension was diluted and plated on nutrient agar. After 24 hours incubation colonies were counted. As can be seen, the cell number decreased only slightly during the experiment. The effect of ripostatin A on various macromolecular syntheses in Staphylococcus aureus is shown in Fig. 5 .
The experiments were done as recently described2). Ripostatin was added at the same time when the reaction was started with labeled precursors. DNAsynthesis ( To confirm that RNAsynthesis was the primary target, the effect ofripostatin on isolated RNApolymerase from E. coli (EC 2.7.7.6, Boehringer Mannheim) was studied (Figs. 6 and 7) . The antibiotic blocked the enzyme with an IC50 of 0.1 /ig/ml. Complete inhibition was achieved at 50/^g/ml. Fig. 7 shows the kinetics of uridinephosphate incorporation into RNA. The mixture was divided 3 minutes after the reaction had been started. To one half, 45fig ripostatin A/ml was added, to the other one an equivalent volumeof methanol. As can be b Mutant with altered outer membrane. (å ) Control, (O) with 2 x MIC, (A) with 10 x MIC seen the rate of RNAsynthesis was only slightly reduced under these conditions. Table 3 shows the effect of ripostatin A on wheat germ RNApolymerase II. This enzymeis insensitive to the antibiotic up to at least 20/zg/ml. Table 4 gives the number of spontaneous mutants of Staphylococcus aureus resistant to ripostatin A and cross-resistance data for ripostatin and two other inhibitors of eubacterial RNApolymerase, viz., rifampicin and sorangicin. Staphylococcus aureus was cloned and 100 clones were examined for sensitivity against MICof ripostatin. Resistant colonies were counted, and the spontaneous mutation frequency was calculated. Thenone clone resistant to either one of the three antibiotics, respectively, was used for determination of crossresistance. While there was a high cross-resistance between rifampicin and sorangicin, no cross-resistance was observed at all between ripostatin and rifampicin or The antibiotic was added 3 minutes after the polymerization reaction had been started. Mutation frequency: rifampicin-resistant 7.0 x l0"8, sorangicin-resistant 6.6 x lO~8, ripostatin-resistant 2.9 x in-8 sorangicm.
Discussion
The ripostatins are macrolides of a novel type. The inhibitory spectrum comprised only bacteria and was rather narrow. The reason for the resistance of most bacteria to ripostatin seems to be a penetration barrier and not the destruction of ripostatin. While yeasts and fungi were insensitive against component A, ripostatin B showed minor activity against some yeasts and fungi ( Table 2 ). No differences between the components were seen in cell cultures, which were rather insensitive to the antibiotic, anyway.
The primary target of ripostatin was eubacterial RNA polymerase. Kinetic studies suggest that chain initiation rather than chain elongation of RNAsynthesis was inhibited ( Fig. 7) . This is the same mechanism as is known for rifampicin3) and sorangicin2), but it is different from that of another myxobacterial RNApolymerase inhibitor, corallopyronin4). Recently a high cross-resistance between rifampicin and sorangicin has been shown with E. coli5). But ripostatin-resistant mutants of Staphylococcus aureus were not resistant to rifampicin or sorangicin, and vice versa. So the binding site of ripostatin seems to be well separated from those of rifampicin and sorangicin within the RNApolymerase.
After myxopyronin6), the chemically related corallopyronins4'7), and sorangicin2), ripostatin is the fourth novel antibiotic isolated by us from myxobacteria, which acts specifically on eubacterial RNApolymerase. This is a rare mechanismof action, and its frequent occurence amongthe relatively few antibacterial substances of myxobacterial origin characterized so far is remarkable.
